Patent Assignment
Reel/Frame 068234/0416
Assignment of Assignor's Interest
Recorded: 2024-07-31
Pages: 2
Assignor
SHANGHAI SYNTHEALL PHARMACEUTICALS
Executed: 2024-07-25
Assignee
BIOMEA FUSION, INC.
900 MIDDLEFIELD ROAD, 4TH FLOOR, REDWOOD CITY, CALIFORNIA, 94063
Covered Properties
(3)
Crystalline Forms of N-[4-[4-(4-Morpholinyl)-7H-Pyrrolo[2,3-D]Pyrimidin-6-Yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Propen-1-Yl)Amino]-1-Piperidinyl]Methyl]-2-Pyridinecarboxamide as a Covalent Inhibitor of Menin-Mll Interaction
PCT:
PCT/US2024/011830 ↗
Crystalline Forms of N-[4-[4-(4-Morpholinyl)-7H-Pyrrolo[2,3-D]Pyrimidin-6-Yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Propen-1-Yl)Amino]-1-Piperidinyl]Methyl]-2-Pyridinecarboxamide as a Covalent Inhibitor of Menin-Mll Interaction
PCT:
PCT/US2024/011848 ↗
CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 26, 2024
From: PUPPALI, SATISH GOUD; WONG, ANGELINA SAU MAN; QIU, YIHONG; KIRSCHBERG, THORSTEN A.
To: BIOMEA FUSION, INC.
Reel/Frame 068089/0636 →
Assignment of Assignor's Interest
Jul 26, 2024
From: LI, SHUANG; ZHOU, YANJING; GU, YUYAO; ZHENG, BO
To: SHANGHAI SYNTHEALL PHARNMACEUTICALS
Reel/Frame 068089/0649 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 068089 Frame: 0649. Assignor(S) Hereby Confirms the Assignment .
Jul 31, 2024
From: LI, SHUANG; ZHOU, YANJING; GU, YUYAO; ZHENG, BO
To: SHANGHAI SYNTHEALL PHARMACEUTICALS
Reel/Frame 068202/0888 →